The article highlights a critical deficiency in standard Indian health check-ups, which are designed to detect established diseases rather than pre-disease metabolic problems, as illustrated by a marketing executive experiencing fatigue and weight gain despite seemingly normal test results. Six key indicators that are often overlooked include unmeasured fasting insulin, which can remain high for years as the pancreas compensates for rising blood sugar; the triglyceride-to-HDL ratio, a strong early sign of insulin resistance; increasing waist circumference despite normal BMI, indicating dangerous visceral fat; acanthosis nigricans (darkening skin patches) and skin tags, visible markers of high insulin; borderline blood pressure readings, often linked to insulin resistance; and mild fatty liver, a significant metabolic warning sign in non-drinkers. The author argues that these issues are detectable with existing data and that early identification allows for reversible metabolic decline, preventing the development of chronic conditions.

The article highlights a critical deficiency in standard Indian health check-ups, which are designed to detect established diseases rather than pre-disease metabolic problems, as illustrated by a marketing executive experiencing fatigue and weight gain despite seemingly normal test results. Six key indicators that are often overlooked include unmeasured fasting insulin, which can remain high for years as the pancreas compensates for rising blood sugar; the triglyceride-to-HDL ratio, a strong early sign of insulin resistance; increasing waist circumference despite normal BMI, indicating dangerous visceral fat; acanthosis nigricans (darkening skin patches) and skin tags, visible markers of high insulin; borderline blood pressure readings, often linked to insulin resistance; and mild fatty liver, a significant metabolic warning sign in non-drinkers. The author argues that these issues are detectable with existing data and that early identification allows for reversible metabolic decline, preventing the development of chronic conditions.

The article highlights a critical deficiency in standard Indian health check-ups, which are designed to detect established diseases rather than pre-disease metabolic problems, as illustrated by a marketing executive experiencing fatigue and weight gain despite seemingly normal test results. Six key indicators that are often overlooked include unmeasured fasting insulin, which can remain high for years as the pancreas compensates for rising blood sugar; the triglyceride-to-HDL ratio, a strong early sign of insulin resistance; increasing waist circumference despite normal BMI, indicating dangerous visceral fat; acanthosis nigricans (darkening skin patches) and skin tags, visible markers of high insulin; borderline blood pressure readings, often linked to insulin resistance; and mild fatty liver, a significant metabolic warning sign in non-drinkers. The author argues that these issues are detectable with existing data and that early identification allows for reversible metabolic decline, preventing the development of chronic conditions.

A 38-year-old marketing executive came to me last month, annual health report in hand, genuinely puzzled. Everything read "normal," he said, so why was he wiped out by four in the afternoon and slowly growing a paunch he'd never had? His glucose was fine. His cholesterol sat "within range." And yet his body was already three or four years into a metabolic problem no one had bothered to name.

This is the quiet failure of the standard Indian check-up. It's designed to catch disease after it arrives, not to spot the long slide that comes before it. Six signals routinely slip through.

1. Fasting insulin is never tested. Your glucose can stay perfectly normal for years while your pancreas works harder and harder, pumping out rising insulin to hold the line. By the time sugar finally climbs, the trouble has been brewing for a decade. A single fasting insulin reading reveals what glucose alone hides.

2. Nobody calculates the triglyceride-to-HDL ratio. Both numbers sit right there on your lipid panel, yet few doctors actually divide one by the other. A high ratio is among the earliest fingerprints of insulin resistance, often showing up well before blood sugar does.

3. Your waist is widening while your weight looks fine. BMI misses the fat that matters most, the visceral fat packed around your liver and pancreas. A slim person with a soft middle can be metabolically sicker than someone heavier but stronger.

4. The dark patches at your neck go unexamined. Velvety darkening around the neck or underarms, along with small skin tags, are visible markers of high insulin. Patients often assume it's a hygiene issue. It's biochemistry.

5. "Borderline" blood pressure gets waved off. Slightly raised readings in your thirties are rarely random. More often, they reflect the same insulin resistance driving everything else, and they deserve a closer look rather than easy reassurance.

6. "Mild fatty liver" is noted and forgotten. It appears on the ultrasound, earns one line in the report, and everyone moves on. But a fatty liver in someone who barely drinks is a loud warning that the metabolism is already struggling.

None of this needs exotic or expensive testing. It needs better questions asked of the results you may already have. The reason this matters is simple: caught at this stage, the slide is still reversible. Most of what we comfortably label "lifelong disease" is, in its early years, a window of opportunity we keep walking past.

He is the founder of Redial Clinic and a specialist in reversing diabetes, hypertension, obesity & PCOS without medication. 

The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK. 

TAGS